{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:02:10Z","timestamp":1779760930736,"version":"3.53.1"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2020YFA0509400"],"award-info":[{"award-number":["2020YFA0509400"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81930101"],"award-info":[{"award-number":["81930101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Research Foundation of Guangzhou Municipal Science and Technology Bureau","award":["SL2024A03J01245"],"award-info":[{"award-number":["SL2024A03J01245"]}]},{"name":"the Research Funds of the State Key Laboratory of Ophthalmology","award":["2025QZSPT48"],"award-info":[{"award-number":["2025QZSPT48"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-026-02650-5","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T23:04:13Z","timestamp":1776207853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["CDK6\/4 inactivates BAP1 deubiquitinase destabilizing VHL to promote metastatic colonization in liver"],"prefix":"10.1186","volume":"25","author":[{"given":"Bei","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijia","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinqiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyun","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peirong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingxuan","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"5","key":"2650_CR1","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ccell.2023.03.018","volume":"41","author":"HB Lengel","year":"2023","unstructured":"Lengel HB, Mastrogiacomo B, Connolly JG, Tan KS, Liu Y, Fick CN, et al. Genomic mapping of metastatic organotropism in lung adenocarcinoma. Cancer Cell. 2023;41(5):970\u201385. e3.","journal-title":"Cancer Cell"},{"issue":"3","key":"2650_CR2","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Fong C, Luthra A, Smith SA, DiNatale RG, Nandakumar S, et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 2022;185(3):563\u201375. e11.","journal-title":"Cell"},{"issue":"3","key":"2650_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.devcel.2019.04.012","volume":"49","author":"Y Gao","year":"2019","unstructured":"Gao Y, Bado I, Wang H, Zhang W, Rosen JM, Zhang XH. Metastasis Organotropism: Redefining the Congenial Soil. Dev Cell. 2019;49(3):375\u201391.","journal-title":"Dev Cell"},{"issue":"1","key":"2650_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","volume":"6","author":"MJ Jager","year":"2020","unstructured":"Jager MJ, Shields CL, Cebulla CM, Abdel-Rahman MH, Grossniklaus HE, Stern MH, et al. Uveal melanoma. Nat Rev Dis Primers. 2020;6(1):24.","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"2650_CR5","first-page":"670","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerg Biol Principles Metastasis Cell. 2017;168(4):670\u201391.","journal-title":"Emerg Biol Principles Metastasis Cell"},{"issue":"1","key":"2650_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12943-020-01173-x","volume":"19","author":"B Jin","year":"2020","unstructured":"Jin B, Zhang P, Zou H, Ye H, Wang Y, Zhang J, et al. Verification of EZH2 as a druggable target in metastatic uveal melanoma. Mol Cancer. 2020;19(1):52.","journal-title":"Mol Cancer"},{"issue":"1","key":"2650_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1038\/s41392-021-00563-x","volume":"6","author":"W Dai","year":"2021","unstructured":"Dai W, Liu S, Wang S, Zhao L, Yang X, Zhou J, et al. Activation of transmembrane receptor tyrosine kinase DDR1-STAT3 cascade by extracellular matrix remodeling promotes liver metastatic colonization in uveal melanoma. Signal Transduct Target Ther. 2021;6(1):176.","journal-title":"Signal Transduct Target Ther"},{"issue":"10","key":"2650_CR8","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1038\/modpathol.2014.43","volume":"27","author":"AE Koopmans","year":"2014","unstructured":"Koopmans AE, Verdijk RM, Brouwer RW, van den Bosch TP, van den Berg MM, Vaarwater J, et al. Clinical significance of immunohistochemistry for detection of BAP1 mutations in uveal melanoma. Mod Pathol. 2014;27(10):1321\u201330.","journal-title":"Mod Pathol"},{"issue":"2","key":"2650_CR9","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1159\/000502550","volume":"6","author":"TR See","year":"2020","unstructured":"See TR, Stalhammar G, Phillips S, Grossniklaus HE. BAP1 Immunoreactivity Correlates with Gene Expression Class in Uveal Melanoma. Ocul Oncol Pathol. 2020;6(2):129\u201337.","journal-title":"Ocul Oncol Pathol"},{"issue":"7","key":"2650_CR10","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1038\/bjc.2014.417","volume":"111","author":"H Kalirai","year":"2014","unstructured":"Kalirai H, Dodson A, Faqir S, Damato BE, Coupland SE. Lack of BAP1 protein expression in uveal melanoma is associated with increased metastatic risk and has utility in routine prognostic testing. Br J Cancer. 2014;111(7):1373\u201380.","journal-title":"Br J Cancer"},{"issue":"6","key":"2650_CR11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1097\/PAS.0000000000000645","volume":"40","author":"JA van de Nes","year":"2016","unstructured":"van de Nes JA, Nelles J, Kreis S, Metz CH, Hager T, Lohmann DR, et al. Comparing the Prognostic Value of BAP1 Mutation Pattern, Chromosome 3 Status, and BAP1 Immunohistochemistry in Uveal Melanoma. Am J Surg Pathol. 2016;40(6):796\u2013805.","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"2650_CR12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s12032-013-0541-8","volume":"30","author":"J Tang","year":"2013","unstructured":"Tang J, Xi S, Wang G, Wang B, Yan S, Wu Y, et al. Prognostic significance of BRCA1-associated protein 1 in colorectal cancer. Med Oncol. 2013;30(2):541.","journal-title":"Med Oncol"},{"issue":"7","key":"2650_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.jtho.2022.04.008","volume":"17","author":"A Louw","year":"2022","unstructured":"Louw A, Panou V, Szejniuk WM, Meristoudis C, Chai SM, van Vliet C, et al. BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study. J Thorac Oncol. 2022;17(7):921\u201330.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"2650_CR14","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ccell.2022.12.001","volume":"41","author":"Y Li","year":"2023","unstructured":"Li Y, Lih TM, Dhanasekaran SM, Mannan R, Chen L, Cieslik M, et al. Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness. Cancer Cell. 2023;41(1):139\u201363. e17.","journal-title":"Cancer Cell"},{"issue":"2","key":"2650_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","volume":"28","author":"L Masclef","year":"2021","unstructured":"Masclef L, Ahmed O, Estavoyer B, Larrivee B, Labrecque N, Nijnik A, et al. Roles and mechanisms of BAP1 deubiquitinase in tumor suppression. Cell Death Differ. 2021;28(2):606\u201325.","journal-title":"Cell Death Differ"},{"issue":"5","key":"2650_CR16","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1158\/0008-5472.CAN-17-2876","volume":"78","author":"H Peng","year":"2018","unstructured":"Peng H, Prokop J, Karar J, Park K, Cao L, Harbour JW, et al. Familial and Somatic BAP1 Mutations Inactivate ASXL1\/2-Mediated Allosteric Regulation of BAP1 Deubiquitinase by Targeting Multiple Independent Domains. Cancer Res. 2018;78(5):1200\u201313.","journal-title":"Cancer Res"},{"issue":"1","key":"2650_CR17","doi-asserted-by":"publisher","first-page":"4883","DOI":"10.1038\/s41467-024-49391-x","volume":"15","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Xie G, Lee JE, Zandian M, Sudarshan D, Estavoyer B, et al. ASXLs binding to the PHD2\/3 fingers of MLL4 provides a mechanism for the recruitment of BAP1 to active enhancers. Nat Commun. 2024;15(1):4883.","journal-title":"Nat Commun"},{"issue":"7","key":"2650_CR18","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/ng.2323","volume":"44","author":"S Pena-Llopis","year":"2012","unstructured":"Pena-Llopis S, Vega-Rubin-de-Celis S, Liao A, Leng N, Pavia-Jimenez A, Wang S, et al. BAP1 loss defines a new class of renal cell carcinoma. Nat Genet. 2012;44(7):751\u20139.","journal-title":"Nat Genet"},{"issue":"6","key":"2650_CR19","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1002\/glia.24351","volume":"71","author":"P Duong","year":"2023","unstructured":"Duong P, Ramesh R, Schneider A, Won S, Cooper AJ, Svaren J. Modulation of Schwann cell homeostasis by the BAP1 deubiquitinase. Glia. 2023;71(6):1466\u201380.","journal-title":"Glia"},{"issue":"6101","key":"2650_CR20","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1126\/science.1221711","volume":"337","author":"A Dey","year":"2012","unstructured":"Dey A, Seshasayee D, Noubade R, French DM, Liu J, Chaurushiya MS, et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science. 2012;337(6101):1541\u20136.","journal-title":"Science"},{"issue":"17","key":"2650_CR21","doi-asserted-by":"publisher","first-page":"6953","DOI":"10.1158\/0008-5472.CAN-08-0365","volume":"68","author":"KH Ventii","year":"2008","unstructured":"Ventii KH, Devi NS, Friedrich KL, Chernova TA, Tighiouart M, Van Meir EG, et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 2008;68(17):6953\u201362.","journal-title":"Cancer Res"},{"key":"2650_CR22","doi-asserted-by":"publisher","first-page":"8471","DOI":"10.1038\/ncomms9471","volume":"6","author":"J Qin","year":"2015","unstructured":"Qin J, Zhou Z, Chen W, Wang C, Zhang H, Ge G, et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. Nat Commun. 2015;6:8471.","journal-title":"Nat Commun"},{"issue":"2","key":"2650_CR23","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","volume":"18","author":"S Landreville","year":"2012","unstructured":"Landreville S, Agapova OA, Matatall KA, Kneass ZT, Onken MD, Lee RS, et al. Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma. Clin Cancer Res. 2012;18(2):408\u201316.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2650_CR24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13238-020-00754-2","volume":"12","author":"YK Xia","year":"2021","unstructured":"Xia YK, Zeng YR, Zhang ML, Liu P, Liu F, Zhang H, et al. Tumor-derived neomorphic mutations in ASXL1 impairs the BAP1-ASXL1-FOXK1\/K2 transcription network. Protein Cell. 2021;12(7):557\u201377.","journal-title":"Protein Cell"},{"issue":"21","key":"2650_CR25","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1128\/MCB.00396-10","volume":"30","author":"H Yu","year":"2010","unstructured":"Yu H, Mashtalir N, Daou S, Hammond-Martel I, Ross J, Sui G, et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol Cell Biol. 2010;30(21):5071\u201385.","journal-title":"Mol Cell Biol"},{"key":"2650_CR26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41525-020-00157-6","volume":"5","author":"JH Hong","year":"2020","unstructured":"Hong JH, Chong ST, Lee PH, Tan J, Heng HL, Ishak NDB, et al. Functional characterisation guides classification of novel BAP1 germline variants. NPJ Genom Med. 2020;5:50.","journal-title":"NPJ Genom Med"},{"issue":"5574","key":"2650_CR27","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1126\/science.1073440","volume":"296","author":"JH Min","year":"2002","unstructured":"Min JH, Yang H, Ivan M, Gertler F, Kaelin WG Jr., Pavletich NP. Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. Science. 2002;296(5574):1886\u20139.","journal-title":"Science"},{"issue":"6","key":"2650_CR28","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41419-024-06844-x","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang S, Li H, Liu X, Yin T, Li T, Zheng M, et al. VHL suppresses UBE3B-mediated breast tumor growth and metastasis. Cell Death Dis. 2024;15(6):446.","journal-title":"Cell Death Dis"},{"issue":"1","key":"2650_CR29","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41420-024-01919-2","volume":"10","author":"Z Shen","year":"2024","unstructured":"Shen Z, Dong T, Yong H, Deng C, Chen C, Chen X, et al. FBXO22 promotes glioblastoma malignant progression by mediating VHL ubiquitination and degradation. Cell Death Discov. 2024;10(1):151.","journal-title":"Cell Death Discov"},{"key":"2650_CR30","doi-asserted-by":"crossref","unstructured":"Wei R, Ren X, Kong H, Lv Z, Chen Y, Tang Y et al. Rb1\/Rbl1\/Vhl loss induces mouse subretinal angiomatous proliferation and hemangioblastoma. JCI Insight. 2019;4(22).","DOI":"10.1172\/jci.insight.127889"},{"issue":"19","key":"2650_CR31","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1182\/blood-2012-11-469296","volume":"121","author":"L Lanikova","year":"2013","unstructured":"Lanikova L, Lorenzo F, Yang C, Vankayalapati H, Drachtman R, Divoky V, et al. Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer. Blood. 2013;121(19):3918\u201324.","journal-title":"Blood"},{"issue":"7585","key":"2650_CR32","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nature16475","volume":"529","author":"SB Lee","year":"2016","unstructured":"Lee SB, Frattini V, Bansal M, Castano AM, Sherman D, Hutchinson K, et al. An ID2-dependent mechanism for VHL inactivation in cancer. Nature. 2016;529(7585):172\u20137.","journal-title":"Nature"},{"issue":"1","key":"2650_CR33","first-page":"21","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY, Jackson RA, Thiery JP. Emt: 2016 Cell. 2016;166(1):21\u201345.","journal-title":"Emt: 2016 Cell"},{"issue":"4","key":"2650_CR34","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.tips.2023.01.003","volume":"44","author":"AE Shin","year":"2023","unstructured":"Shin AE, Giancotti FG, Rustgi AK. Metastatic colorectal cancer: mechanisms and emerging therapeutics. Trends Pharmacol Sci. 2023;44(4):222\u201336.","journal-title":"Trends Pharmacol Sci"},{"issue":"11","key":"2650_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/S0960-9822(00)00221-9","volume":"4","author":"Z Songyang","year":"1994","unstructured":"Songyang Z, Blechner S, Hoagland N, Hoekstra MF, Piwnica-Worms H, Cantley LC. Use of an oriented peptide library to determine the optimal substrates of protein kinases. Curr Biol. 1994;4(11):973\u201382.","journal-title":"Curr Biol"},{"issue":"5","key":"2650_CR36","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.ccr.2011.10.001","volume":"20","author":"L Anders","year":"2011","unstructured":"Anders L, Ke N, Hydbring P, Choi YJ, Widlund HR, Chick JM, et al. A systematic screen for CDK4\/6 substrates links FOXM1 phosphorylation to senescence suppression in cancer cells. Cancer Cell. 2011;20(5):620\u201334.","journal-title":"Cancer Cell"},{"key":"2650_CR37","doi-asserted-by":"crossref","unstructured":"Kalluri R, LeBleu VS. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478).","DOI":"10.1126\/science.aau6977"},{"issue":"11","key":"2650_CR38","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1158\/0008-5472.CAN-22-2945","volume":"84","author":"BA Brown","year":"2024","unstructured":"Brown BA, Myers PJ, Adair SJ, Pitarresi JR, Sah-Teli SK, Campbell LA, et al. A Histone Methylation-MAPK Signaling Axis Drives Durable Epithelial-Mesenchymal Transition in Hypoxic Pancreatic Cancer. Cancer Res. 2024;84(11):1764\u201380.","journal-title":"Cancer Res"},{"issue":"8","key":"2650_CR39","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1073\/pnas.1018866109","volume":"109","author":"SJ Conley","year":"2012","unstructured":"Conley SJ, Gheordunescu E, Kakarala P, Newman B, Korkaya H, Heath AN, et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A. 2012;109(8):2784\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1\u20132","key":"2650_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s10555-018-09777-y","volume":"38","author":"O Thews","year":"2019","unstructured":"Thews O, Riemann A. Tumor pH and metastasis: a malignant process beyond hypoxia. Cancer Metastasis Rev. 2019;38(1\u20132):113\u201329.","journal-title":"Cancer Metastasis Rev"},{"issue":"6577","key":"2650_CR41","doi-asserted-by":"publisher","first-page":"eabc1495","DOI":"10.1126\/science.abc1495","volume":"375","author":"A Fassl","year":"2022","unstructured":"Fassl A, Geng Y, Sicinski P. CDK4 and CDK6 kinases: From basic science to cancer therapy. Science. 2022;375(6577):eabc1495.","journal-title":"Science"},{"issue":"10","key":"2650_CR42","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","volume":"20","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Shi J, Liu X, Feng L, Gong Z, Koppula P, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol. 2018;20(10):1181\u201392.","journal-title":"Nat Cell Biol"},{"issue":"4","key":"2650_CR43","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/s41556-018-0071-x","volume":"20","author":"S Nowsheen","year":"2018","unstructured":"Nowsheen S, Aziz K, Aziz A, Deng M, Qin B, Luo K, et al. L3MBTL2 orchestrates ubiquitin signalling by dictating the sequential recruitment of RNF8 and RNF168 after DNA damage. Nat Cell Biol. 2018;20(4):455\u201364.","journal-title":"Nat Cell Biol"},{"issue":"8","key":"2650_CR44","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1158\/0008-5472.CAN-19-1704","volume":"80","author":"HJ Lee","year":"2020","unstructured":"Lee HJ, Pham T, Chang MT, Barnes D, Cai AG, Noubade R, et al. The Tumor Suppressor BAP1 Regulates the Hippo Pathway in Pancreatic Ductal Adenocarcinoma. Cancer Res. 2020;80(8):1656\u201368.","journal-title":"Cancer Res"},{"issue":"1","key":"2650_CR45","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1002\/1878-0261.12844","volume":"15","author":"R Deng","year":"2021","unstructured":"Deng R, Guo Y, Li L, He J, Qiang Z, Zhang H, et al. BAP1 suppresses prostate cancer progression by deubiquitinating and stabilizing PTEN. Mol Oncol. 2021;15(1):279\u201398.","journal-title":"Mol Oncol"},{"issue":"10","key":"2650_CR46","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.trecan.2019.08.005","volume":"5","author":"D Mennerich","year":"2019","unstructured":"Mennerich D, Kubaichuk K, Kietzmann T. DUBs, Hypoxia, and Cancer. Trends Cancer. 2019;5(10):632\u201353.","journal-title":"Trends Cancer"},{"issue":"6","key":"2650_CR47","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.7150\/thno.41120","volume":"10","author":"N Jiang","year":"2020","unstructured":"Jiang N, Zou C, Zhu Y, Luo Y, Chen L, Lei Y, et al. HIF-1a-regulated miR-1275 maintains stem cell-like phenotypes and promotes the progression of LUAD by simultaneously activating Wnt\/beta-catenin and Notch signaling. Theranostics. 2020;10(6):2553\u201370.","journal-title":"Theranostics"},{"issue":"11","key":"2650_CR48","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1038\/s41418-023-01228-8","volume":"30","author":"M Mu","year":"2023","unstructured":"Mu M, Zhang Q, Li J, Zhao C, Li X, Chen Z, et al. USP51 facilitates colorectal cancer stemness and chemoresistance by forming a positive feed-forward loop with HIF1A. Cell Death Differ. 2023;30(11):2393\u2013407.","journal-title":"Cell Death Differ"},{"key":"2650_CR49","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12943-016-0510-x","volume":"15","author":"DL Brooks","year":"2016","unstructured":"Brooks DL, Schwab LP, Krutilina R, Parke DN, Sethuraman A, Hoogewijs D, et al. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models. Mol Cancer. 2016;15:26.","journal-title":"Mol Cancer"},{"issue":"15","key":"2650_CR50","doi-asserted-by":"publisher","first-page":"4191","DOI":"10.1158\/0008-5472.CAN-18-0270","volume":"78","author":"H Lu","year":"2018","unstructured":"Lu H, Tran L, Park Y, Chen I, Lan J, Xie Y, et al. Reciprocal Regulation of DUSP9 and DUSP16 Expression by HIF1 Controls ERK and p38 MAP Kinase Activity and Mediates Chemotherapy-Induced Breast Cancer Stem Cell Enrichment. Cancer Res. 2018;78(15):4191\u2013202.","journal-title":"Cancer Res"},{"issue":"4","key":"2650_CR51","first-page":"229","volume":"16","author":"A Mullard","year":"2017","unstructured":"Mullard A. FDA approves Novartis\u2019s CDK4\/6 inhibitor. Nat Rev Drug Discov. 2017;16(4):229.","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"2650_CR52","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.ccr.2007.01.014","volume":"11","author":"A Vecchione","year":"2007","unstructured":"Vecchione A, Baldassarre G, Ishii H, Nicoloso MS, Belletti B, Petrocca F, et al. Fez1\/Lzts1 absence impairs Cdk1\/Cdc25C interaction during mitosis and predisposes mice to cancer development. Cancer Cell. 2007;11(3):275\u201389.","journal-title":"Cancer Cell"},{"issue":"49","key":"2650_CR53","doi-asserted-by":"publisher","first-page":"34179","DOI":"10.1074\/jbc.M109.046755","volume":"284","author":"YJ Machida","year":"2009","unstructured":"Machida YJ, Machida Y, Vashisht AA, Wohlschlegel JA, Dutta A. The deubiquitinating enzyme BAP1 regulates cell growth via interaction with HCF-1. J Biol Chem. 2009;284(49):34179\u201388.","journal-title":"J Biol Chem"},{"issue":"8","key":"2650_CR54","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1128\/MCB.01517-08","volume":"29","author":"S Misaghi","year":"2009","unstructured":"Misaghi S, Ottosen S, Izrael-Tomasevic A, Arnott D, Lamkanfi M, Lee J, et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol Cell Biol. 2009;29(8):2181\u201392.","journal-title":"Mol Cell Biol"},{"issue":"7933","key":"2650_CR55","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/s41586-022-05312-w","volume":"610","author":"R Feng","year":"2022","unstructured":"Feng R, Mayuranathan T, Huang P, Doerfler PA, Li Y, Yao Y, et al. Activation of gamma-globin expression by hypoxia-inducible factor 1alpha. Nature. 2022;610(7933):783\u201390.","journal-title":"Nature"},{"issue":"2","key":"2650_CR56","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1038\/s41419-024-06552-6","volume":"15","author":"A Gao","year":"2024","unstructured":"Gao A, Zhang M, Zhu SQ, Zou S, Chen H, Li X, et al. DNA polymerase iota promotes EMT and metastasis of esophageal squamous cell carcinoma by interacting with USP7 to stabilize HIF-1alpha. Cell Death Dis. 2024;15(2):171.","journal-title":"Cell Death Dis"},{"issue":"9","key":"2650_CR57","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1172\/JCI138577","volume":"130","author":"H Lu","year":"2020","unstructured":"Lu H, Xie Y, Tran L, Lan J, Yang Y, Murugan NL, et al. Chemotherapy-induced S100A10 recruits KDM6A to facilitate OCT4-mediated breast cancer stemness. J Clin Invest. 2020;130(9):4607\u201323.","journal-title":"J Clin Invest"},{"issue":"12","key":"2650_CR58","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1093\/stcltm\/szad061","volume":"12","author":"GL Semenza","year":"2023","unstructured":"Semenza GL. Mechanisms of Breast Cancer Stem Cell Specification and Self-Renewal Mediated by Hypoxia-Inducible Factor 1. Stem Cells Transl Med. 2023;12(12):783\u201390.","journal-title":"Stem Cells Transl Med"},{"issue":"3","key":"2650_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/ncb1691","volume":"10","author":"MH Yang","year":"2008","unstructured":"Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, et al. Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol. 2008;10(3):295\u2013305.","journal-title":"Nat Cell Biol"},{"issue":"5","key":"2650_CR60","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/s41556-024-01409-8","volume":"26","author":"AW Lambert","year":"2024","unstructured":"Lambert AW, Zhang Y, Weinberg RA. Cell-intrinsic and microenvironmental determinants of metastatic colonization. Nat Cell Biol. 2024;26(5):687\u201397.","journal-title":"Nat Cell Biol"},{"issue":"6399","key":"2650_CR61","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1126\/science.aap8411","volume":"361","author":"J Zhang","year":"2018","unstructured":"Zhang J, Wu T, Simon J, Takada M, Saito R, Fan C, et al. VHL substrate transcription factor ZHX2 as an oncogenic driver in clear cell renal cell carcinoma. Science. 2018;361(6399):290\u20135.","journal-title":"Science"},{"issue":"1","key":"2650_CR62","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.ygyno.2003.10.029","volume":"92","author":"H Brustmann","year":"2004","unstructured":"Brustmann H. Expression of cellular apoptosis susceptibility protein in serous ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecol Oncol. 2004;92(1):268\u201376.","journal-title":"Gynecol Oncol"},{"key":"2650_CR63","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, Athar M, et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022;25:18\u201327.","journal-title":"Neoplasia"},{"key":"2650_CR64","doi-asserted-by":"publisher","first-page":"115625","DOI":"10.1016\/j.bcp.2023.115625","volume":"213","author":"B Jin","year":"2023","unstructured":"Jin B, Yang L, Ye Q, Pan J. Ferroptosis induced by DCPS depletion diminishes hepatic metastasis in uveal melanoma. Biochem Pharmacol. 2023;213:115625.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"2650_CR65","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41581-020-00359-2","volume":"17","author":"J Eric","year":"2020","unstructured":"Eric J, Cheryl Lyn W, Kimryn Rathmell W. Clear cell renal cell carcinoma ontogeny and mechanisms of lethality. Nat Rev Nephrol. 2020;17(4):245\u201361. https:\/\/doi.org\/10.1038\/s41581-020-00359-2.","journal-title":"Nat Rev Nephrol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-026-02650-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-026-02650-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T01:02:34Z","timestamp":1779757354000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-026-02650-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2650"],"URL":"https:\/\/doi.org\/10.1186\/s12943-026-02650-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"2 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The specimens of patients were conducted with permission from the Institutional Research Ethics Committee of Sun Yat-sen University Zhongshan Ophthalmic Center. All animal experiments were carried out in accordance with a protocol approved by the ethics committee of the Institutional Animal Care of Sun Yat-sen University Zhongshan Ophthalmic Center (approval protocol no. IACUC-2022-001060).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}